2.73 (-%)
As of Nov 21, 2024
Source:
Trevi Therapeutics, Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio for the treatment of chronic cough in idiopathic pulmonary fibrosis, or IPF, and refractory chronic cough, or RCC.
| Country | United States |
| Headquarters | new haven, connecticut |
| Phone Number | (203) 304-2499 |
| Industry | manufacturing |
| CEO | Jennifer Good |
| Website | www.trevitherapeutics.com |